LEX Diagnostics Appoints Ed Farrell as Chief Executive Officer

CAMBRIDGESHIRE, United Kingdom, Feb. 21, 2023  – LEX Diagnostics announces the appointment of Ed Farrell as its new Chief Executive Officer.

Read full release.

You might also like
Valo Therapeutics Announces First Patient Dosed with PeptiCRAd-1 – Innovative Immuno-oncology
IRBM Selected for Participation in National Chemical Biology Consortium
Needle-free vaccine delivery platform aims to end frozen storage needs and improve access
VaxEquity and CPI Announce Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics
Anocca raises SEK 400 million for large-scale development of cancer cell therapies
BC Platforms appoints Dr Carolin Bender as Chief Medical Officer
SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
Laevoroc Immunology Announces FDA Orphan Drug Designation Granted to LR 09, a Novel Metabolic Immune Checkpoint Inhibitor for the Treatment of Leukemia Relapse after Allogeneic Stem Cell Transplant